These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27531677)

  • 1. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism.
    Marcos-Contreras OA; Martinez de Lizarrondo S; Bardou I; Orset C; Pruvost M; Anfray A; Frigout Y; Hommet Y; Lebouvier L; Montaner J; Vivien D; Gauberti M
    Blood; 2016 Nov; 128(20):2423-2434. PubMed ID: 27531677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
    Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
    Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
    Yepes M; Sandkvist M; Moore EG; Bugge TH; Strickland DK; Lawrence DA
    J Clin Invest; 2003 Nov; 112(10):1533-40. PubMed ID: 14617754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.
    Emerich DF; Dean RL; Osborn C; Bartus RT
    Clin Pharmacokinet; 2001; 40(2):105-23. PubMed ID: 11286321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.
    Su EJ; Cao C; Fredriksson L; Nilsson I; Stefanitsch C; Stevenson TK; Zhao J; Ragsdale M; Sun YY; Yepes M; Kuan CY; Eriksson U; Strickland DK; Lawrence DA; Zhang L
    Acta Neuropathol; 2017 Oct; 134(4):585-604. PubMed ID: 28725968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1-INH.
    Khosravani F; Suvorava T; Dao VT; Brockmann N; Kocgirli O; Herbst FF; Valcaccia S; Kassack MU; Bas M; Kojda G
    Allergy; 2015 Mar; 70(3):285-94. PubMed ID: 25477154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system.
    Bartus RT; Elliott P; Hayward N; Dean R; McEwen EL; Fisher SK
    Immunopharmacology; 1996 Jun; 33(1-3):270-8. PubMed ID: 8856161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.
    Niego B; Freeman R; Puschmann TB; Turnley AM; Medcalf RL
    Blood; 2012 May; 119(20):4752-61. PubMed ID: 22262761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.
    Desposito D; Chollet C; Taveau C; Descamps V; Alhenc-Gelas F; Roussel R; Bouby N; Waeckel L
    Clin Sci (Lond); 2016 Jan; 130(1):45-56. PubMed ID: 26443866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients.
    Cardenas JC; Matijevic N; Baer LA; Holcomb JB; Cotton BA; Wade CE
    Shock; 2014 Jun; 41(6):514-21. PubMed ID: 24667610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.
    Sashindranath M; Sales E; Daglas M; Freeman R; Samson AL; Cops EJ; Beckham S; Galle A; McLean C; Morganti-Kossmann C; Rosenfeld JV; Madani R; Vassalli JD; Su EJ; Lawrence DA; Medcalf RL
    Brain; 2012 Nov; 135(Pt 11):3251-64. PubMed ID: 22822039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bradykinin in the antifibrotic actions of perindoprilat on human mesangial cells.
    Pawluczyk IZ; Patel SR; Harris KP
    Kidney Int; 2004 Apr; 65(4):1240-51. PubMed ID: 15086463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.
    Chapman MP; Moore EE; Moore HB; Gonzalez E; Gamboni F; Chandler JG; Mitra S; Ghasabyan A; Chin TL; Sauaia A; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2016 Jan; 80(1):16-23; discussion 23-5. PubMed ID: 26491796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.
    Zalfa C; Azmoon P; Mantuano E; Gonias SL
    J Leukoc Biol; 2019 Apr; 105(4):729-740. PubMed ID: 30690783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
    Rakkar K; Srivastava K; Bayraktutan U
    Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood-brain barrier disruption.
    Yao Y; Tsirka SE
    J Cell Sci; 2011 May; 124(Pt 9):1486-95. PubMed ID: 21486949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema.
    Bisha M; Dao VT; Gholamreza-Fahimi E; Vogt M; van Zandvoort M; Weber S; Bas M; Khosravani F; Kojda G; Suvorava T
    Br J Pharmacol; 2018 May; 175(10):1607-1620. PubMed ID: 29465763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.